Methods and compositions for transdermal delivery
US9949952B2 · kind B2 · utility
0Cited by
5References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 28, 2015 |
| Grant date | Apr 24, 2018 |
| Priority date | — |
| Expiry date | May 28, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0043
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
One aspect of the invention relates to AI-helper compositions comprising an AI compound (e.g., melatonin) and one or more helper esters. The AI-helper compositions disclosed herein can be used for effective transdermal delivery of the AI compound to a subject. Another aspect of the invention relates to applications and preparations of the AI-helper compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.